RS

Ravi Shankar Prasad Singh

Active Director Director DIN 08967787
DIN 08967787 First appointment Nov 2020 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Shankar Prasad Singh

Data last updated:

Ravi Shankar Prasad Singh is a Director at Medicamake Biopharma Private Limited (since 2020). The company operates in Food And Beverages.

DIN 08967787
Primary Designation Director
Industry Food And Beverages
First Appointment 21 Nov 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicamake Biopharma Private Limited U24304BR2020PTC049322
Director21 Nov 20202020Active

Board colleagues of Ravi Shankar Prasad Singh

NameDINCompanyDesignation
Raja Kumar08967788Medicamake Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medicamake Biopharma Private Limited
Premium access

Shareholding and investment profile for Ravi Shankar Prasad Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shankar Prasad Singh

Ravi Shankar Prasad Singh currently holds 1 directorship: Medicamake Biopharma Private Limited (Director, since 21 Nov 2020).

Ravi Shankar Prasad Singh was first appointed on 21 Nov 2020 as Director at Medicamake Biopharma Private Limited.

The current boards of Ravi Shankar Prasad Singh's companies include Raja Kumar (Medicamake Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available